Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

Lets COMPARE this 3rd Quarter and 2016 3rd Quarter - SHALL WE:

MAY 2016
OS - 122.5 Million Shares
CASH ON HAND - 5.3 Million
CASH Available via ASPIRE - 25 Million
SHELF REG - 45 Million

OVERVIEW OF PIPELINE:
K - Still in Phase 1 at DF and BIDMC
P - Enrollment complete in phase 2a waiting on data at the time the Q came out
B - Submitted SPA for Absssi phase 3 - Received comments back from FDA - CTIX discussing next steps
B-OM - Phase 2 underway and they replaced the CRO during this period due to lack of progress

MAY 2017
OS - 131.3 Million Shares
CASH ON HAND - 5.6 Million
CASH Available via ASPIRE - 16 Million
Shelf Reg - 45 Million

OVERVIEW OF PIPELINE:
K - Completed Phase 1 and provided data; Initiated a phase 2 trial for OC
k- ORAL Formulation underway --- Bridging tox studies started in Jan 2017
P - Data for phase 2a was successful; Initiated a phase 2b trial with dosing much higher
B Absssi - Decided to hold tight on B phase 3 for Absssi while share price was so low to limit dilution for a 30 million trial
B-OM - Released interim data that was phenomenal but the data was only for about 20 patients. Recruitment still underway
B-UP - Initiated a phase 2 PoC trial - this is in the final cohort and data looks superb to date!

____________________________________________________
So - yes the OS went up about 9 Million since last year same time. But CTIX was able to start 3 NEW mid stage trials and begin bridge tox studies for K Oral with that money. I'd say GREAT JOB CTIX!!!!